FXR, the primary BA receptor, modulates glucose homeostasis by enhancing insulin sensitivity and inhibiting hepatic gluconeogenesis, thereby mitigating obesity [29]. Here, NR1H4 is linked to obesity due to melanocortin 4 receptor deficiency.